Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,474.00    -8.00 (-0.54%)
Bid:
1,472.00
Ask:
1,480.00
Spread: 8.00 (0.543%)
Market Cap: £768.11m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Acquisition

6 Mar 2023 07:00

RNS Number : 8974R
M. P. Evans Group PLC
06 March 2023
 

M.P. EVANS GROUP PLC

("The Group" or "M.P.Evans")

 

ACQUISITION OF PLANTED LAND IN INDONESIA

 

The board of M.P.Evans, the producer of sustainable palm oil, is pleased to announce, in line with its growth strategy, the acquisition, for cash, of additional planted land, adjacent to the Group's Simpang Kiri estate, in Indonesia.

 

The Group has been successful in acquiring 100% of the shares in two Indonesian companies, PT Teunggulon Raya and PT Dharma Agung, which between them own 2,100 hectares planted with oil palm. All the land being acquired is fully titled, with long leaseholds already established with the Indonesian government, in a similar way to the Group's existing properties. The planted land is close to the Group's Simpang Kiri estate in Aceh Province, Northern Sumatra. Total costs associated with the acquisition, including the assumption of liabilities within the companies acquired, are estimated to be US$14.3 million, giving rise to a purchase cost of US$6,800 per hectare. The Group does expect to replant some of the acquired areas in the near term, as part of its plans to bring them up to Group standards.

 

Following the acquisition, the Group will have an expanded planted area of 4,800 hectares at or around the Simpang Kiri estate, and the potential to build its own palm-oil mill there. If one is developed, the Group would reach a position of processing 100% of its own crop, as well as further increasing its sustainable palm-oil production.

 

Commenting on the acquisition, Peter Hadsley-Chaplin, executive chairman, said:

 

"This is an excellent acquisition, fully in keeping with our stated strategy and supported by the strength of the Group's balance sheet. Thanks to a combination of the good price at which it has been secured, and the added scale it gives the Group around Simpang Kiri, these additional hectares are further fuel for the M.P.Evans growth engine."

 

6 March 2023

 

Enquiries:

M.P. Evans Group PLC

+44 (0)1892 516333

Peter Hadsley-Chaplin

Executive chairman

Matthew Coulson

Chief executive

Luke Shaw

Chief financial officer

Peel Hunt LLP (Nomad and joint broker)

+44 (0)20 7418 8900

Dan Webster, Andrew Clark, Lalit Bose

finnCap (Joint broker)

+44 (0)20 7220 0500

Tim Redfern, Harriet Ward

Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Charlie Jack, Francis Kerrigan, Amelia Craddock

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUPUAUWUPWGAW
Date   Source Headline
18th May 20207:00 amRNSTransaction in Own Shares
13th May 20207:00 amRNSTransaction in Own Shares
11th May 20207:00 amRNSTransaction in Own Shares
7th May 20207:00 amRNSTransaction in Own Shares
6th May 20207:00 amRNSTransaction in Own Shares
5th May 20207:00 amRNSTransaction in Own Shares
1st May 20208:59 amRNSTotal Voting Rights
1st May 20207:00 amRNSTransaction in Own Shares
27th Apr 20207:00 amRNSTransaction in Own Shares
22nd Apr 20207:00 amRNSTransaction in Own Shares
21st Apr 20207:00 amRNSTransaction in Own Shares
20th Apr 20206:15 pmRNSAllotment of Shares and Total Voting Rights
20th Apr 20207:00 amRNSTransaction in Own Shares
17th Apr 20207:00 amRNSTransaction in Own Shares
15th Apr 20207:00 amRNSBlock listing application
15th Apr 20207:00 amRNSTransaction in Own Shares
14th Apr 20207:00 amRNSTransaction in Own Shares
9th Apr 20207:00 amRNSTransaction in Own Shares
8th Apr 20207:00 amRNSTransaction in Own Shares
6th Apr 20204:54 pmRNSAnnual Financial Report posting
1st Apr 20207:00 amRNSTotal Voting Rights
31st Mar 20207:00 amRNSFinal Results
27th Mar 202011:50 amRNSResults presentation update
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20207:00 amRNSTransaction in Own Shares
18th Mar 20207:00 amRNSTransaction in Own Shares
17th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20207:00 amRNSTransaction in Own Shares
12th Mar 20207:00 amRNSTransaction in Own Shares
11th Mar 20207:00 amRNSTransaction in Own Shares
10th Mar 20204:42 pmRNSNotice of Results
10th Mar 20207:00 amRNSTransaction in Own Shares
6th Mar 20207:00 amRNSTransaction in Own Shares
5th Mar 20207:00 amRNSTransaction in Own Shares
4th Mar 20207:00 amRNSTransaction in Own Shares
3rd Mar 20209:53 amRNSTotal Voting Rights
3rd Mar 20207:00 amRNSTransaction in Own Shares
2nd Mar 20207:00 amRNSTransaction in Own Shares
25th Feb 20207:00 amRNSTransaction in Own Shares
7th Feb 20207:00 amRNSTransaction in Own Shares
5th Feb 20207:00 amRNSTransaction in Own Shares
24th Jan 20207:00 amRNSPublication of Sustainability Report
10th Jan 20209:50 amRNSDirector/PDMR Shareholding
9th Jan 20207:00 amRNSCrop and production update
2nd Jan 20201:53 pmRNSTotal Voting Rights
2nd Jan 20207:00 amRNSBlock listing Interim Review
13th Dec 20197:00 amRNSShare buyback programme
12th Dec 20197:00 amRNSTransaction in Own Shares
11th Dec 20197:00 amRNSTransaction in Own Shares
10th Dec 20197:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.